US Broker Ratings

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Powerhouse with 141.76% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is emerging as a significant player in the biotechnology sector, attracting attention with its innovative approach to cell therapies, particularly in..

Agilent Technologies, Inc. (A) Stock Analysis: Evaluating Growth Potential with a 7.79% Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing investment opportunity for those..

Humana Inc. (HUM) Stock Analysis: Exploring a 7% Potential Upside in the Healthcare Sector

Humana Inc. (NYSE: HUM), a key player in the healthcare plans industry, has caught the attention of investors with its robust market presence and promising growth..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling an 18% Potential Upside amid Robust Revenue Growth

Corcept Therapeutics Incorporated (NASDAQ: CORT), a noteworthy player in the biotechnology industry, is capturing investor attention with its promising growth metrics and significant upside potential. With..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling Growth Potential with a 9.84% Upside

TransMedics Group, Inc. (TMDX) stands as a pioneering force in the healthcare sector, specifically within the medical devices industry. This U.S.-based company has carved a niche..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a Volatile Journey in TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based firm specializing in Traditional Chinese Medicine (TCM), presents a unique investment opportunity within the healthcare sector. Despite..

RadNet, Inc. (RDNT) Stock Analysis: A 21.64% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Los Angeles, California, RadNet..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a Potential 43% Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its innovative approach to treating B-cell mediated diseases. Founded in 1993 and headquartered..

Glaukos Corporation (GKOS) Stock Analysis: Assessing Growth Potential Amid a Robust Revenue Surge

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its significant market presence..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 19.47% Potential Upside with Robust Revenue Growth

CVS Health Corporation (NYSE: CVS), a heavyweight in the healthcare sector, is capturing investor attention with a compelling proposition of a 19.47% potential upside according to..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Glimpse into the 14.86% Potential Upside

Investors keeping an eye on the healthcare sector might want to delve deeper into Jazz Pharmaceuticals plc (NASDAQ: JAZZ). With a market capitalization of $15.9 billion,..

Nuvalent, Inc. (NUVL) Stock Analysis: Steady at $123.96 with Phase 2 Clinical Trials on the Horizon

For investors focused on the biotechnology sector, Nuvalent, Inc. (NASDAQ: NUVL) presents a unique profile as a clinical-stage biopharmaceutical company targeting breakthrough therapies for cancer patients...

Avantor, Inc. (AVTR) Stock Analysis: Navigating Growth Amidst Healthcare Industry Volatility

Avantor, Inc. (NYSE: AVTR) stands as a significant player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of..

DexCom, Inc. (DXCM): Investor Outlook on a Leading Medical Device Innovator with Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM) stands out in the healthcare sector as a prominent player in the medical devices industry, specializing in continuous glucose monitoring (CGM) systems...

Vertex Pharmaceuticals (VRTX) Stock Analysis: Evaluating the 11.34% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, commanding attention with its robust market cap of $128.19 billion. Operating at..

Biogen Inc. (BIIB) Investor Outlook: Exploring a Promising 13.23% Potential Upside

Biogen Inc. (BIIB), a stalwart in the healthcare sector, has long been recognized for its innovative therapies and robust pipeline in the drug manufacturing industry. With..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring Growth Potential with RAS-Targeted Therapies

Revolution Medicines, Inc. (NASDAQ: RVMD), a prominent player in the biotechnology sector, is drawing significant attention from investors with its cutting-edge approach to precision oncology. Headquartered..

Repligen Corporation (RGEN)

⚠️ No article content returned.

..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 31.96% Potential Upside with Strong Buy Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH) continues to capture the attention of investors with its diverse portfolio of over-the-counter (OTC) healthcare and personal care products. Headquartered..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Assessing the 12.59% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a global leader in the healthcare sector, continues to capture the attention of investors with its diverse portfolio and strategic..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds